Investigating point-of-care diagnostics for sexually transmitted infections and antimicrobial resistance in antenatal care in Zimbabwe (IPSAZ): protocol for a mixed-methods study.
Female
Pregnancy
Humans
Prenatal Care
Anti-Bacterial Agents
/ therapeutic use
Syphilis
/ diagnosis
Zimbabwe
Prospective Studies
Chlamydia Infections
/ diagnosis
Drug Resistance, Bacterial
Sexually Transmitted Diseases
/ diagnosis
Gonorrhea
/ diagnosis
Trichomonas vaginalis
Neisseria gonorrhoeae
Chlamydia trachomatis
Hepatitis B
Prevalence
Point-of-Care Testing
HIV Infections
/ diagnosis
GENITOURINARY MEDICINE
HEALTH ECONOMICS
HIV & AIDS
MICROBIOLOGY
OBSTETRICS
Public health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
20 04 2023
20 04 2023
Historique:
medline:
24
4
2023
pubmed:
21
4
2023
entrez:
20
04
2023
Statut:
epublish
Résumé
Sexually transmitted infections (STIs) can cause serious morbidity, including pelvic inflammatory disease, and adverse pregnancy outcomes. In low/middle-income countries, limited laboratory infrastructure has resulted in a syndrome-based approach being used for management of STIs, which has poor sensitivity and specificity, leading to considerable underdiagnosis and overtreatment. The WHO has called for development and evaluation of strategies to inform replacement of syndromic management by diagnostic testing.The aim of this project is to evaluate a strategy of point-of-care testing for six STIs in antenatal care (ANC) in Zimbabwe. A prospective interventional study will be conducted in ANC clinics in Harare province, Zimbabwe. One thousand pregnant women will be recruited when registering for routine ANC. Alongside routine HIV and syphilis testing, participants will be offered an integrated screening package including testing for The study protocol was approved by the Medical Research Council of Zimbabwe, the Biomedical Research and Training Institute Institutional Review Board, and the London School of Hygiene & Tropical Medicine Research Ethics Committee. Results will be submitted to open-access peer-reviewed journals, presented at academic meetings and shared with participating communities and with national and international policymaking bodies. NCT05541081.
Identifiants
pubmed: 37080628
pii: bmjopen-2022-070889
doi: 10.1136/bmjopen-2022-070889
pmc: PMC10124298
doi:
Substances chimiques
Anti-Bacterial Agents
0
Banques de données
ClinicalTrials.gov
['NCT05541081']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e070889Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Bull World Health Organ. 2019 Aug 01;97(8):548-562P
pubmed: 31384073
Sex Transm Dis. 2016 Jul;43(7):450-8
pubmed: 27322048
PLoS One. 2019 Jul 1;14(7):e0218349
pubmed: 31260486
PLoS One. 2017 Jul 21;12(7):e0181267
pubmed: 28732085
PLoS One. 2018 Apr 24;13(4):e0196209
pubmed: 29689080
Vaccine. 2013 Nov 12;31(47):5579-84
pubmed: 23973500
S Afr Med J. 2014 Apr;104(4):307-9
pubmed: 25118561
BMC Infect Dis. 2010 May 21;10:127
pubmed: 20492681
Nurse Res. 2004 Sep 1;12(1):82-83
pubmed: 28718745
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
BMC Infect Dis. 2021 Dec 8;21(1):1234
pubmed: 34879820
Matern Child Health J. 2014 Oct;18(8):1795-802
pubmed: 24337865
Sex Transm Infect. 2021 Aug;97(5):375-381
pubmed: 33004610
J Infect Dis. 2021 Dec 15;224(12):2085-2093
pubmed: 34023871
Lancet Child Adolesc Health. 2021 Feb;5(2):122-132
pubmed: 33417838
PLoS Med. 2017 Jul 7;14(7):e1002344
pubmed: 28686231
Lancet Infect Dis. 2019 Jun;19(6):658-669
pubmed: 31031172
Sex Transm Dis. 2014 Dec;41(12):713-7
pubmed: 25581806
Sex Health. 2019 Sep;16(5):412-425
pubmed: 31437420
Sex Transm Dis. 2015 Jan;42(1):43-7
pubmed: 25504300
Sex Transm Infect. 2017 Dec;93(S4):S81-S88
pubmed: 29223966
Emerg Infect Dis. 2017 Oct;23(13):
pubmed: 29155673
Sex Transm Infect. 2006 Dec;82 Suppl 5:v1-6
pubmed: 17151023
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Int J STD AIDS. 2020 Nov;31(13):1282-1290
pubmed: 32960744
Prev Med. 2003 Apr;36(4):502-9
pubmed: 12649059
Sex Transm Infect. 2017 Dec;93(S4):S31-S35
pubmed: 28684611
Sex Transm Infect. 2013 Dec;89(8):672-8
pubmed: 24005255
Sex Transm Infect. 2018 Feb;94(1):62-66
pubmed: 28476914
Am J Trop Med Hyg. 2016 Nov 2;95(5):1069-1076
pubmed: 27672205
Sex Transm Dis. 2018 Jan;45(1):56-60
pubmed: 29240635
Bull World Health Organ. 2021 Apr 1;99(4):287-295
pubmed: 33953446
BMC Health Serv Res. 2022 Feb 10;22(1):171
pubmed: 35144602
Sex Transm Infect. 1999 Feb;75(1):3-17
pubmed: 10448335
Sex Transm Infect. 2005 Aug;81(4):294-302
pubmed: 16061534